Cargando…

Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development

Detalles Bibliográficos
Autores principales:	Hasegawa, Hideaki, Mizoguchi, Izuru, Orii, Naoko, Inoue, Shinya, Katahira, Yasuhiro, Yoneto, Toshihiko, Xu, Mingli, Miyazaki, Toru, Yoshimoto, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566579/ https://www.ncbi.nlm.nih.gov/pubmed/34732798 http://dx.doi.org/10.1038/s41598-021-01575-x

Ejemplares similares

IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
por: Hasegawa, Hideaki, et al.
Publicado: (2021)

A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions
por: Watanabe, Aruma, et al.
Publicado: (2021)

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
por: Hasegawa, Hideaki, et al.
Publicado: (2016)

Induction of potent antitumor immunity by intradermal DNA injection using a novel needle‐free pyro‐drive jet injector
por: Inoue, Shinya, et al.
Publicado: (2022)

Potent antitumor effects of the conditioned medium of bone marrow‐derived mesenchymal stem cells via IGFBP‐4
por: Furusaka, Yuma, et al.
Publicado: (2023)

Protective effects of conditioned media of immortalized stem cells from human exfoliated deciduous teeth on pressure ulcer formation
por: Katahira, Yasuhiro, et al.
Publicado: (2023)

Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation
por: Sakamoto, Eri, et al.
Publicado: (2023)

Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
por: Xu, Mingli, et al.
Publicado: (2010)

A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant
por: Sonoda, Jukito, et al.
Publicado: (2023)

Prediction of Chemical Respiratory and Contact Sensitizers by OX40L Expression in Dendritic Cells Using a Novel 3D Coculture System
por: Mizoguchi, Izuru, et al.
Publicado: (2017)

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse
por: Yoshimoto, Takayuki, et al.
Publicado: (2014)

Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
por: Qu, Ning, et al.
Publicado: (2013)

Potential clinical application of interleukin-27 as an antitumor agent
por: Yoshimoto, Takayuki, et al.
Publicado: (2015)

Case report: two cases of extremely rare primary pure squamous cell carcinoma of the breast
por: Yoneto, Toshihiko, et al.
Publicado: (2018)

Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report
por: Yoneto, Toshihiko, et al.
Publicado: (2023)

A Pivotal Role for Interleukin-27 in CD8(+) T Cell Functions and Generation of Cytotoxic T Lymphocytes
por: Morishima, Noriko, et al.
Publicado: (2010)

A patient with stage IIIB advanced breast cancer who is still alive 24 years after surgery: a case report and remarks on the treatment strategies
por: Yoneto, Toshihiko, et al.
Publicado: (2022)

Regulation of inflammatory immune responses leading to the development of bone destructive autoimmune disease rheumatoid arthritis by IL-27
por: Yoshimoto, Takayuki, et al.
Publicado: (2012)

Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells
por: Ito, Tomoko, et al.
Publicado: (2021)

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
por: Ohyashiki, Junko H, et al.
Publicado: (2014)

IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner
por: Chiba, Yukino, et al.
Publicado: (2013)

Author Correction: Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF
por: Mizoguchi, Takahiro, et al.
Publicado: (2018)

Tricking an ancient immune function to eradicate hepatocellular carcinoma
por: Miyazaki, Toru, et al.
Publicado: (2015)

Author Correction: First Evidence of Coherent Bands of Strong Turbulent Layers Associated with High-Wavenumber Internal-Wave Shear in the Upstream Kuroshio
por: Nagai, Takeyoshi, et al.
Publicado: (2018)

Heterodimeric Plasmonic Nanogaps for Biosensing
por: Chatterjee, Sharmistha, et al.
Publicado: (2018)

Heterodimeric DNA motif synthesis and validations
por: Wong, Ka-Chun, et al.
Publicado: (2019)

Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Correction for Euro Surveill. 2020;25(23)
Publicado: (2021)

Authors’ correction for Euro Surveill. 2018;23(46)
Publicado: (2018)

Authors’ correction for Euro Surveill. 2018;23(28)
Publicado: (2018)

Authors’ correction for Euro Surveill. 2018;23(50)
Publicado: (2019)

Authors’ correction for Euro Surveill. 2018;23(29)
Publicado: (2018)

Authors’ correction for Euro Surveill. 2018;23(29)
Publicado: (2018)

Authors’ correction for Euro Surveill. 2018;23(5)
Publicado: (2018)

Authors’ correction for Euro Surveill. 2018;23(39)
Publicado: (2018)

Authors’ correction for Euro Surveill. 2020;25(23)
Publicado: (2020)

Authors’ correction for Euro Surveill. 2018;23(33)
Publicado: (2021)

Emerging Roles of TWIK-1 Heterodimerization in the Brain
por: Cho, Chang-Hoon, et al.
Publicado: (2017)

Early Archean origin of heterodimeric Photosystem I
por: Cardona, Tanai
Publicado: (2018)

Quantitative Supramolecular Heterodimerization for Efficient Energy Transfer
por: Wu, Guanglu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sch9frg22qasntuik9avr0m3kj